Insights & Opinions

Insights, opinions and commentaries from experts in the biobanking field. Contribute an Article

Do We Need Biobankers at All?

No one can tell the number of biobanks worldwide. Several years ago, I was involved in a survey at a university center in Switzerland. We wanted to find out how many biobanks there were in this center. A biobank...
Speed is Important in Biobanking but the Promises must be Kept

Speed is Important in Biobanking but the Promises Must be Kept

Hofstadter's Law is the observation that a process will always take longer than expected, even when Hofstadter's Law is taken into account. In other words, time estimates of how long something will take to accomplish will always fall short...
Challenges in biobanking: Underutilization of Samples

Challenges in Biobanking: Underutilization of Samples

When it comes to predictions, I agree with Nobel Prize winner Niels Bohr: "Prediction is very difficult, especially if it's about the future”. Nevertheless, I dare to predict that there will be some consolidation in biobanks in the next...

The Anatomy of a Refrigeration Failure: What Happens at 2:00 a.m. When Mission Critical...

Article contributed by Chris Wilkes, chief commercial officer at KLATU Networks, Inc. Ultralow temperature (ULT) freezers often contain high-value biopharmaceuticals and/or irreplaceable research. When you leave at the end of the day or for the weekend, you need confidence that...
Metabio

The Need for Patient-Pushed, Real-World Data on Neurodegenerative Diseases

Neurodegenerative diseases, is a collective term for a group of disorders characterized by the progressive neurodegeneration of brain cells, leading to dysfunction(s) and abnormal structure(s) in the central and/or peripheral nervous systems. One of the main causes of neurodegeneration...

Biobanks – A Platform for Modern Biomedical Research

Without biomedical research, medicine, as we know it, would be nothing more than a machine gun affair. In simpler words, biomedical research is the substratum that supports evidence-based medicine. Biomedical researchers study biological and pathological processes in order to...

What can Biobanks Learn From the Current Pandemic?

More than a year ago, something happened that most of us could hardly imagine. A virus took the whole world more or less firmly in its grip. Pandemic, previously a word that very few of us knew, has now...

Interview with Dr. Tony Cox OBE, CEO at UK Biocentre

UK Biocentre is a not-for-profit organisation providing world-leading sample management and high-capacity bioprocessing services to biomedical researchers. They provide sample collection, sample logistics, processing, nucleic acidic extraction, sample storage, and shipping management. UK Biocentre is currently commissioned by the UK...

Interview with Jill Mullan, Chief Operating Officer at iSpecimen

Every medical breakthrough starts with the study of afflicted patients, often through their blood, tumor tissue, or other biological material. Thus, it’s critical for the advancement of life science research that scientists can easily procure the human biospecimens they...

How Biobanks Can Support Personalized Medicine

Biobanks should be an integral part of a comprehensive research platform, not exclusively viewed as a service provider or freezer farm managed with excel sheets. For biobanks to be be viewed as a contributing partner and one that can...

⭐ Recently Featured

🔥 Popular Posts

X